Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Neurovirol ; 21(5): 508-17, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26002839

RESUMEN

Blinding ocular herpetic disease in humans is due to herpes simplex virus type 1 (HSV-1) reactivations from latency, rather than to primary acute infection. The cellular and molecular immune mechanisms that control the HSV-1 latency-reactivation cycle remain to be fully elucidated. The aim of this study was to determine if reactivation of the HSV-1 latency-associated transcript (LAT) deletion mutant (dLAT2903) was impaired in this model, as it is in the rabbit model of induced and spontaneous reactivation and in the trigeminal ganglia (TG) explant-induced reactivation model in mice. The eyes of mice latently infected with wild-type HSV-1 strain McKrae (LAT((+)) virus) or dLAT2903 (LAT((-)) virus) were irradiated with UV-B, and reactivation was determined. We found that compared to LAT((-)) virus, LAT((+)) virus reactivated at a higher rate as determined by shedding of virus in tears on days 3 to 7 after UV-B treatment. Thus, the UV-B-induced reactivation mouse model of HSV-1 appears to be a useful small animal model for studying the mechanisms involved in how LAT enhances the HSV-1 reactivation phenotype. The utility of the model for investigating the immune evasion mechanisms regulating the HSV-1 latency/reactivation cycle and for testing the protective efficacy of candidate therapeutic vaccines and drugs is discussed.


Asunto(s)
Herpesvirus Humano 1/fisiología , Queratitis Herpética/virología , MicroARNs/genética , Activación Viral/genética , Latencia del Virus/genética , Animales , Modelos Animales de Enfermedad , Femenino , Ratones , Ratones Endogámicos C57BL , Rayos Ultravioleta
2.
Ophthalmology ; 120(4): e21-7, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23395545

RESUMEN

OBJECTIVE: To compare intraocular pressure (IOP) measurements in children 18 years of age and younger using rebound tonometry and applanation tonometry and the feasibility of using these techniques in children. METHODS: Literature searches of the PubMed and the Cochrane Library databases were last conducted in June 2012 and resulted in 43 citations, including citations not in English. Of these 43 citations, 4 studies met the inclusion criterion following full text review. A level of evidence rating was assigned to each study using criteria specifically developed for this assessment. RESULTS: No level I study was found in the literature search, and 2 level II and 2 level III studies were identified. Intraocular pressure was 2 to 3 mmHg higher using rebound tonometry compared with Goldmann applanation tonometry in the 2 level II studies performed in a clinic setting and in 1 level III study performed on children under general anesthesia. However, IOP was lower in 1 level III study in which noncontact applanation tonometry was compared with rebound tonometry. Bland-Altman plots showed that the difference in IOP for rebound versus Goldmann applanation tonometry increased as the IOP increased. The success rate for measuring IOP was markedly higher in children 3 years of age and younger using rebound tonometry compared with noncontact tonometry in 1 level III study. CONCLUSIONS: Rebound tonometry seems to be a reasonably accurate instrument that allows the IOP to be measured in many children without using general anesthesia. More data are required to assess better how the differences between instruments vary with IOP measurement.


Asunto(s)
Academias e Institutos , Glaucoma/diagnóstico , Presión Intraocular , Oftalmología/métodos , Tonometría Ocular/instrumentación , Niño , Diseño de Equipo , Humanos
3.
Ophthalmology ; 120(9): 1935-41, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23820078

RESUMEN

OBJECTIVE: To evaluate the severity of postoperative inflammation, degree of patient discomfort, adequacy of wound closure, and length of operating time when using fibrin glue compared with sutures to close limbal conjunctival incisions after strabismus surgery. METHODS: Literature searches of the PubMed and Cochrane Library databases were last conducted on January 24, 2013, and resulted in 24 citations, including 2 not in the English language. All citations were reviewed in full text. Five studies compared fibrin glue (68 eyes) with sutures (74 eyes) for closure of limbal conjunctival incisions in patients undergoing strabismus surgery and were included in this assessment; no studies were found that evaluated fornix incisions. A quality rating was assigned to each study using criteria specifically developed for this assessment. RESULTS: No level I studies were found, and 5 level II studies were identified. There was significantly less postoperative inflammation and patient discomfort for 1 to 3 weeks after strabismus surgery for eyes treated with fibrin glue compared with sutures. In 3 studies that evaluated wound apposition, 2 of 50 eyes (4%) with conjunctival incisions that were initially closed using fibrin glue subsequently developed a wound gap that required suture repair. In the 2 studies that compared surgical time, fibrin glue required 1 to 5 minutes less time than suturing in 1 study and 55% less time (3.8 vs. 8.4 minutes) in a second study. These 5 studies did not evaluate the cost-effectiveness or risk of viral transmission from fibrin glue. CONCLUSIONS: Studies in the literature suggest that the off-label use of fibrin glue to close limbal conjunctival incisions in strabismus surgery resulted in less postoperative inflammation and required shorter operating time compared with sutures, but it increased the percentage of wounds requiring subsequent repair with sutures. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.


Asunto(s)
Conjuntiva/cirugía , Adhesivo de Tejido de Fibrina/uso terapéutico , Estrabismo/cirugía , Adhesivos Tisulares/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Academias e Institutos , Humanos , Inflamación/tratamiento farmacológico , Oftalmología , Satisfacción del Paciente , Complicaciones Posoperatorias , Técnicas de Sutura , Evaluación de la Tecnología Biomédica , Estados Unidos
4.
Ophthalmology ; 119(6): 1272-80, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22541632

RESUMEN

OBJECTIVE: To evaluate the accuracy of detecting clinically significant retinopathy of prematurity (ROP) using wide-angle digital retinal photography. METHODS: Literature searches of PubMed and the Cochrane Library databases were conducted last on December 7, 2010, and yielded 414 unique citations. The authors assessed these 414 citations and marked 82 that potentially met the inclusion criteria. These 82 studies were reviewed in full text; 28 studies met inclusion criteria. The authors extracted from these studies information about study design, interventions, outcomes, and study quality. After data abstraction, 18 were excluded for study deficiencies or because they were superseded by a more recent publication. The methodologist reviewed the remaining 10 studies and assigned ratings of evidence quality; 7 studies were rated level I evidence and 3 studies were rated level III evidence. RESULTS: There is level I evidence from ≥5 studies demonstrating that digital retinal photography has high accuracy for detection of clinically significant ROP. Level III studies have reported high accuracy, without any detectable complications, from real-world operational programs intended to detect clinically significant ROP through remote site interpretation of wide-angle retinal photographs. CONCLUSIONS: Wide-angle digital retinal photography has the potential to complement standard ROP care. It may provide advantages through objective documentation of clinical examination findings, improved recognition of disease progression by comparing previous photographs, and the creation of image libraries for education and research. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.


Asunto(s)
Técnicas de Diagnóstico Oftalmológico , Oftalmología/organización & administración , Fotograbar/instrumentación , Retinopatía de la Prematuridad/diagnóstico , Evaluación de la Tecnología Biomédica/organización & administración , Academias e Institutos/organización & administración , Bases de Datos Factuales , Medicina Basada en la Evidencia , Humanos , Recién Nacido , Reproducibilidad de los Resultados , Estados Unidos
5.
Ophthalmology ; 119(4): 873-7, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22381808

RESUMEN

OBJECTIVE: To evaluate the role of cryotherapy in the current treatment of retinopathy of prematurity (ROP). METHODS: Literature searches of PubMed and the Cochrane Library were conducted on December 2, 2009, for articles published after 1984. The searches included all languages and retrieved 187 relevant citations. Thirteen articles were deemed relevant to the assessment question and were rated according to the strength of evidence. Four articles reported results from 2 large multicenter randomized clinical trials, and the remaining 9 articles reported results of 3 small randomized trials that directly compared cryotherapy and laser. RESULTS: Neither of the multicenter randomized clinical trials was a direct comparison of cryotherapy with laser. These studies were used to evaluate the comparative trials based on treatment criteria, study populations, and clinical results. Higher percentages of poor structural and functional outcomes generally were seen in eyes treated with cryotherapy compared with eyes undergoing laser treatment. Higher rates of systemic complications and myopia also were identified after treatment with cryotherapy. CONCLUSIONS: Despite a relative paucity of level I evidence directly comparing cryotherapy and laser treatment for threshold ROP, the literature suggests that neonatal facilities should gain access to laser technology and laser-trained ophthalmic staff to achieve better outcomes for treatment of the disease.


Asunto(s)
Crioterapia , Retinopatía de la Prematuridad/cirugía , Evaluación de la Tecnología Biomédica , Academias e Institutos , Bases de Datos Factuales , Humanos , Recién Nacido , Coagulación con Láser , Oftalmología , Ensayos Clínicos Controlados Aleatorios como Asunto , Retinopatía de la Prematuridad/fisiopatología , Resultado del Tratamiento , Estados Unidos , Agudeza Visual/fisiología
6.
J Virol ; 84(18): 9149-60, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20592089

RESUMEN

Three-dimensional (3D) porcine nasal mucosal and tracheal mucosal epithelial cell cultures were developed to analyze foot-and-mouth disease virus (FMDV) interactions with mucosal epithelial cells. The cells in these cultures differentiated and polarized until they closely resemble the epithelial layers seen in vivo. FMDV infected these cultures predominantly from the apical side, primarily by binding to integrin alphav beta6, in an Arg-Gly-Asp (RGD)-dependent manner. However, FMDV replicated only transiently without any visible cytopathic effect (CPE), and infectious progeny virus could be recovered only from the apical side. The infection induced the production of beta interferon (IFN-beta) and the IFN-inducible gene Mx1 mRNA, which coincided with the disappearance of viral RNA and progeny virus. The induction of IFN-beta mRNA correlated with the antiviral activity of the supernatants from both the apical and basolateral compartments. IFN-alpha mRNA was constitutively expressed in nasal mucosal epithelial cells in vitro and in vivo. In addition, FMDV infection induced interleukin 8 (IL-8) protein, granulocyte-macrophage colony-stimulating factor (GM-CSF), and RANTES mRNA in the infected epithelial cells, suggesting that it plays an important role in modulating the immune response.


Asunto(s)
Células Epiteliales/virología , Virus de la Fiebre Aftosa/fisiología , Replicación Viral , Animales , Antígenos de Neoplasias/metabolismo , Quimiocina CCL5/biosíntesis , Efecto Citopatogénico Viral , Femenino , Virus de la Fiebre Aftosa/inmunología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/biosíntesis , Integrinas/metabolismo , Interferón-alfa/biosíntesis , Interferón beta/biosíntesis , Interleucina-8/biosíntesis , Masculino , Técnicas de Cultivo de Órganos , ARN Mensajero/biosíntesis , Mucosa Respiratoria/virología , Porcinos , Activación Transcripcional , Acoplamiento Viral
7.
Mol Vis ; 17: 2649-54, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22065917

RESUMEN

PURPOSE: The purpose of this study was to assess the ability of quantitative in vivo confocal microscopy (CM) to detect changes in cystine crystal volume in the cystinosisn (Ctns(-/-))mouse cornea following topical cysteamine therapy. METHODS: Fifteen Ctns(-/-) mice were sequentially followed using in vivo CM from 3 to 10 months of age. In a second experiment, five mice receiving topical cysteamine eyedrops (0.55%) for 4 weeks were compared to five untreated mice. The volume of corneal cystine crystals was determined by thresholding and counting high intensity pixels in the in vivo CM scans and dividing by the stromal volume to calculate a crystal volume index (CVI). RESULTS: Corneal crystals progressively increased in density with age, reaching a peak density at 6-8 months and showing a 70 fold increase in CVI. Eyes treated with cysteamine drops showed significantly less crystal accumulation compared to control eyes (p<0.001) with only a 15% increase in treated eyes (p=ns) compared to 173% increase (p<0.04) for untreated eyes. CONCLUSIONS: Measurement of CVI shows that there is a progressive increase in cystine crystal volume up to 8 months of age and that cysteamine eyedrops significantly inhibits progression in the Ctns(-/-) mouse. These findings are similar to those seen clinically in patients with cystinosis, and suggest that measurement of CVI in the Ctns(-/-) mouse may be used as a model to develop novel therapeutic strategies for treating corneal cystinosis.


Asunto(s)
Sistemas de Transporte de Aminoácidos Neutros/deficiencia , Córnea/metabolismo , Cisteamina/administración & dosificación , Cistina/antagonistas & inhibidores , Cistinosis/tratamiento farmacológico , Microscopía Confocal/métodos , Administración Oftálmica , Sistemas de Transporte de Aminoácidos Neutros/genética , Animales , Córnea/efectos de los fármacos , Córnea/patología , Cristalización , Cisteamina/uso terapéutico , Cistina/metabolismo , Cistinosis/diagnóstico , Cistinosis/metabolismo , Cistinosis/fisiopatología , Modelos Animales de Enfermedad , Humanos , Ratones , Ratones Noqueados , Soluciones Oftálmicas/administración & dosificación , Soluciones Oftálmicas/uso terapéutico , Resultado del Tratamiento , Agudeza Visual
8.
J Transcult Nurs ; 19(1): 16-23, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18165422

RESUMEN

This study used phenomenology to explore the experience of Muslim women through descriptions of their encounters with health care providers in a rural area. Participants (N = 7) were eligible for inclusion if the foreign-born woman had lived in the area for at least 2 years, had interaction with a health care provider within the last 6 months, and was able to articulate her experience either in English or through a interpreter. Data were recorded, transcribed, coded, and analyzed for the emergence of reoccurring themes, employing decision trails. Constant comparative analysis was used to promote the integrity of the data. Three themes were identified: (1) perceived power of the provider, (2) religiously defined gender relations, and (3) being a stranger in the U.S. healthcare system. Education of the Muslim patient and the provider is needed to increase health care satisfaction and use by rural Muslim women.


Asunto(s)
Actitud Frente a la Salud/etnología , Islamismo/psicología , Relaciones Profesional-Paciente , Servicios de Salud Rural/organización & administración , Mujeres/psicología , Aculturación , Adulto , Asertividad , Actitud del Personal de Salud/etnología , Competencia Clínica , Barreras de Comunicación , Conducta Cooperativa , Competencia Cultural , Femenino , Identidad de Género , Necesidades y Demandas de Servicios de Salud , Humanos , Investigación Metodológica en Enfermería , Educación del Paciente como Asunto , Poder Psicológico , Rol Profesional/psicología , Investigación Cualitativa , Sudeste de Estados Unidos , Encuestas y Cuestionarios , Mujeres/educación
9.
Sci Rep ; 8(1): 16956, 2018 11 16.
Artículo en Inglés | MEDLINE | ID: mdl-30446704

RESUMEN

The re-emergence of poxviral zoonotic infections and the threat of bioterrorism emphasise the demand for effective antipoxvirus therapies. Here, we show that carbenoxolone, a pharmacological inhibitor of gap junction function and a compound widely used in cell culture, is capable of hindering the replication of Vaccinia virus, the prototypical poxvirus, in a gap junction-independent manner in a human keratinocyte cell line. Viral protein synthesis occurs in the presence of carbenoxolone but infectious virion formation is minimal, indicating that carbenoxolone blocks viral morphogenesis. Initial viability tests suggested that carbenoxolone was not toxic to cells. However, electron microscopic analysis of carbenoxolone treated cells revealed that it alters the cellular endomembrane system. This widespread ultrastructural damage prevents Vaccinia virus virion assembly. These results strengthen the need for thorough characterisation of the effects of antiviral compounds on the cellular ultrastructure.


Asunto(s)
Carbenoxolona/farmacología , Queratinocitos/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Antiulcerosos/farmacología , Antivirales/farmacología , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/ultraestructura , Membrana Celular/virología , Supervivencia Celular/efectos de los fármacos , Humanos , Queratinocitos/citología , Queratinocitos/virología , Microscopía Electrónica de Transmisión , Virus Vaccinia/efectos de los fármacos , Virus Vaccinia/fisiología , Virión/efectos de los fármacos , Virión/metabolismo
10.
Curr Eye Res ; 41(6): 747-56, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26398722

RESUMEN

PURPOSE: Blinding ocular herpetic disease in humans is due to spontaneous reactivation of herpes simplex virus type 1 (HSV-1) from latency, rather than to primary acute infection. Mice latently infected with HSV-1 undergo little or no in vivo spontaneous reactivation with accompanying virus shedding in tears. HSV-1 reactivation can be induced in latently infected mice by several in vivo procedures, with UV-B-induced reactivation being one commonly used method. In the UV-B model, corneas are scarified (lightly scratched) just prior to ocular infection to increase efficiency of the primary infection and immune serum containing HSV-1 neutralizing antibodies is injected intraperitoneally (i.p.) to increase survival and decrease acute corneal damage. Since scarification can significantly alter host gene transcription in the cornea and in the trigeminal ganglia (TG; the site of HSV-1 latency) and since injection of immune serum likely modulates innate and adaptive herpes immunity, we investigated eliminating both treatments. MATERIAL AND METHODS: Mice were infected with HSV-1 with or without corneal scarification and immune serum. HSV-1 reactivation and recurrent disease were induced by UV-B irradiation. RESULTS: When corneal scarification and immune serum were both eliminated, UV-B irradiation still induced both HSV-1 reactivation, as measured by shedding of reactivated virus in tears and herpetic eye disease, albeit at reduced levels compared to the original procedure. CONCLUSION: Despite the reduced reactivation and disease, avoidance of both corneal scarification and immune serum should improve the clinical relevance of the UV-B mouse model.


Asunto(s)
Córnea/patología , Infecciones Virales del Ojo/virología , Herpesvirus Humano 1/fisiología , Sueros Inmunes/administración & dosificación , Queratitis Herpética/virología , Lágrimas/virología , Activación Viral/efectos de la radiación , Animales , Córnea/virología , Modelos Animales de Enfermedad , Infecciones Virales del Ojo/patología , Femenino , Herpesvirus Humano 1/efectos de la radiación , Factores Inmunológicos/administración & dosificación , Queratitis Herpética/terapia , Ratones , Ratones Endogámicos C57BL , Conejos , Rayos Ultravioleta , Latencia del Virus , Esparcimiento de Virus
11.
J AAPOS ; 6(6): 385-8, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12506281

RESUMEN

BACKGROUND: Visual abnormalities have been described in patients with infantile spasms (IS), an epileptic syndrome of early childhood. METHODS: We report on 3 children who exhibited cortically mediated visual regression in association with the development of IS. RESULTS: In 1 patient, loss of visual behavior was the presenting complaint. In all patients, visual behavior improved with treatment of seizures. CONCLUSIONS: IS are a potentially treatable cause of cortically impaired vision in early childhood. Because visual behavior might improve when the seizures are treated, patients should be referred appropriately.


Asunto(s)
Espasmos Infantiles/complicaciones , Trastornos de la Visión/etiología , Anticonvulsivantes/uso terapéutico , Electroencefalografía , Femenino , Humanos , Lactante , Masculino , Convulsiones/complicaciones , Convulsiones/tratamiento farmacológico , Espasmos Infantiles/tratamiento farmacológico , Resultado del Tratamiento , Trastornos de la Visión/fisiopatología , Agudeza Visual
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA